The comparison of clinical and biological characteristics between IDH1 and IDH2 mutations in gliomas

BACKGROUND: Mutations in isocitrate dehydrogenase 1 (IDH1) and isocitrate dehydrogenase 2 (IDH2) are frequent in low-grade gliomas and secondary glioblastomas (sGBM). Because they yield the same oncometabolite, D-2-hydroxyglutarate, they are often treated as equivalent and pooled. The objective of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hao-Yuan, Tang, Kai, Liang, Ting-Yu, Zhang, Wei-Zhong, Li, Ji-Ye, Wang, Wen, Hu, Hui-Min, Li, Ming-Yang, Wang, Hui-Qing, He, Xiao-Zheng, Zhu, Zhi-Yuan, Liu, Yan-Wei, Zhang, Shi-Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888668/
https://www.ncbi.nlm.nih.gov/pubmed/27245697
http://dx.doi.org/10.1186/s13046-016-0362-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888668/
https://www.ncbi.nlm.nih.gov/pubmed/27245697
http://dx.doi.org/10.1186/s13046-016-0362-7

Ejemplares similares